Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sex Disparity in the Burden of Ncds and Its Four Main Subgroups in Iran 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019 Publisher



Fatollahzade M1 ; Bastan MM1 ; Shaabanian M1 ; Golestani A1 ; Tabatabaeimalazy O1 ; Mohajeritehrani M2 ; Amini M3 ; Khosravi S1 ; Pajavand H4 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2024


Abstract

Objectives: The significant health differences between sexes in Iran in terms of burden of non-communicable diseases (NCDs) point to the urgency of developing policies. We aim to explore sex disparities in NCDs. Methods: We used Global Burden of Disease 2019 study to compare estimates of incidence, prevalence, disability-adjusted life years (DALYs), years lived with disabilities (YLDs), years of life lost (YLLs), and deaths among sexes for NCDs, and their main subgroups; neoplasms, cardiovascular diseases (CVDs), chronic respiratory diseases (CRDs), diabetes mellitus (DM) during 1990–2019. Results: In 2019, there were 62,476,274 (59517167.5, 65759931) incident NCDs in men and 78758640.6 (75222093.7, 82272935.8) in women. There were 7734064.3 (6744951.2, 8846192) DALYs in men and 7760484.2 (6496609, 9218299.9) in women. Fatal estimates (deaths and YLLs) of NCDs were higher for men, while non-fatal estimates (prevalence, YLDs) were higher for women. Men were superior in all burden indices of NCDs subgroups, except for all indices of DM and YLDs in CVDs. Compared to 1990–2010, the period 2010–2019 confirmed a marked stagnation in decline rates of burden indices, as well as an increase in incidence and prevalence which was more pronounced among men. Despite shrinking sex gaps in NCDs subgroups since 1990, sex gap in DM is widening in 2019. Conclusions: There is a notable sex disparity in NCDs prevalence in Iran, which has become increasingly evident in DM burden. It will be imperative to continue monitoring sexual differences in NCDs burden to determine if disease rates between sexes continue to diverge in the future. © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024.
Related Docs
View other Related Docs
1. National, Subnational and Risk Attributed Burden of Chronic Respiratory Diseases in Iran From 1990 to 2019, Respiratory Research (2023)
2. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
3. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
4. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
5. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
6. Cardiometabolic Risk Factors Trend in Iranian Adults With Hypertension Over 15 Years: Findings of Nationwide Steps of 2007–2021, Journal of Diabetes and Metabolic Disorders (2024)
7. Trend and Projection of Non-Communicable Diseases Risk Factors in Iran From 2001 to 2030, Scientific Reports (2024)
8. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (32)
Farshad Farzadfar (31)
Other Related Docs
9. The Burden of Type 2 Diabetes Mellitus and Attributable Risk Factors in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Iranian Journal of Public Health (2024)
10. Age–Sex Differences in the Global Burden of Lower Respiratory Infections and Risk Factors, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
11. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
12. The Burden of Metabolic Risk Factors in North Africa and the Middle East, 1990–2019: Findings From the Global Burden of Disease Study, eClinicalMedicine (2023)
13. Non-Communicable Diseases in the Southwest of Iran: Profile and Baseline Data From the Shahrekord Persian Cohort Study, BMC Public Health (2021)
14. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)
15. Temporal Trends in Cardiovascular Disease Risk Factors Attributed Burden in Iran, 1990–2021, Scientific Reports (2025)
16. Global, Regional, and National Burden of Cancers Attributable to Tobacco Smoking in 204 Countries and Territories, 1990–2019, Cancer Medicine (2022)
17. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
18. Protocol Design for Surveillance of Risk Factors of Non–Communicable Diseases During the Covid-19 Pandemic: An Experience From Iran Steps Survey 2021, Archives of Iranian Medicine (2022)
19. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)
20. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, European Journal of Preventive Cardiology (2022)
21. Regional Burden of Chronic Kidney Disease in North Africa and Middle East During 1990–2019; Results From Global Burden of Disease Study 2019, Frontiers in Public Health (2022)
22. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, Chest (2022)
23. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
24. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
25. The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021, Journal of Diabetes and Metabolic Disorders (2023)
26. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
27. Estimation of Myocardial Infarction Death in Iran: Artificial Neural Network, BMC Cardiovascular Disorders (2022)
28. Burden of Female Breast Cancer in The Middle East and North Africa Region, 1990–2019, Archives of Public Health (2022)
29. Assessment and Prioritization of the Who Best Buys and Other Recommended Interventions for the Prevention and Control of Non-Communicable Diseases in Iran, BMC Public Health (2020)
30. Global, Regional, and National Burden of Allergic Disorders and Their Risk Factors in 204 Countries and Territories, From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Allergy: European Journal of Allergy and Clinical Immunology (2023)
31. Prevalence of Plasma Lipid Abnormalities and Associated Risk Factors Among Iranian Adults Based on the Findings From Steps Survey 2021, Scientific Reports (2023)
32. Global, Regional, and National Burden of Migraine in 204 Countries and Territories, 1990 to 2019, Pain (2022)
33. Developing an Organizational Capacity Assessment Tool and Capacity-Building Package for the National Center for Prevention and Control of Noncommunicable Diseases in Iran, PLoS ONE (2023)
34. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
35. Attributable Disease Burden Related to Low Bone Mineral Density in Iran From 1990 to 2019: Results From the Global Burden of Disease 2019, Archives of Osteoporosis (2022)
36. Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Respiratory Medicine (2021)
37. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
38. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
39. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
40. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
41. Global, Regional, and National Mortality Due to Unintentional Carbon Monoxide Poisoning, 2000–2021: Results From the Global Burden of Disease Study 2021, The Lancet Public Health (2023)
42. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)
43. Inequalities in the Prevalence, Diagnosis Awareness, Treatment Coverage and Effective Control of Diabetes: A Small Area Estimation Analysis in Iran, BMC Endocrine Disorders (2023)
44. Risk of Incident Cardiovascular Diseases at National and Subnational Levels in Iran From 2000 to 2016 and Projection Through 2030: Insights From Iran Steps Surveys, PLoS ONE (2023)
45. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
46. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)
47. The State of Health in the European Union (Eu-27) in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, BMC Public Health (2024)
48. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
49. The Role of Genetics and Gender Specific Differences in Neurodegenerative Disorders: Insights From Molecular and Immune Landscape, Journal of Neuroimmunology (2023)
50. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)